Benzimidazole derivative

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S387000

Reexamination Certificate

active

10777067

ABSTRACT:
A benzimidazole derivative or its medically acceptable salt, represented by the following formula (1), that is a human chymase activity inhibitor capable of being applied clinically:wherein, R1and R2represent a hydrogen atom, an alkyl group or an alkoxy group, etc., A represents an alkylene group or an alkenylene group, E represents —COOR3, —SO3R3, —CONHR3or —SO2NHR3, etc., G represents an alkylene group, M represents a single bond or —S(O)m—, J represents a heterocyclic group, and X represents —CH═ or a nitrogen atom.

REFERENCES:
patent: 2336909 (2000-01-01), None
patent: 1 097 926 (2001-05-01), None
patent: 2 430 950 (1980-02-01), None
patent: 62-212386 (1987-09-01), None
patent: 1-265089 (1989-10-01), None
patent: WO 99/26932 (1999-06-01), None
patent: WO 00/03997 (2000-01-01), None
patent: WO 01/00615 (2001-01-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Benzimidazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzimidazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3860405

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.